BR112022024539A2 - Vírus sincicial respiratório vivo atenuado - Google Patents
Vírus sincicial respiratório vivo atenuadoInfo
- Publication number
- BR112022024539A2 BR112022024539A2 BR112022024539A BR112022024539A BR112022024539A2 BR 112022024539 A2 BR112022024539 A2 BR 112022024539A2 BR 112022024539 A BR112022024539 A BR 112022024539A BR 112022024539 A BR112022024539 A BR 112022024539A BR 112022024539 A2 BR112022024539 A2 BR 112022024539A2
- Authority
- BR
- Brazil
- Prior art keywords
- live
- respiratory syncytial
- atenuated
- syncytial virus
- viruses
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18521—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18571—Demonstrated in vivo effect
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Oncology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
VÍRUS SINCICIAL RESPIRATÓRIO VIVO ATENUADO. A presente invenção refere-se a novos vírus sinciciais respiratórios (RSV) recombinantes que têm um fenótipo atenuado. As cepas recombinantes do RSV aqui descritas são adequadas para uso como vacinas de RSV vivo atenuado. Além disso, são providas sequências de polinucleotídeos capazes de codificar os vírus descritos, bem como métodos para produção e uso dos vírus.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202063035617P | 2020-06-05 | 2020-06-05 | |
PCT/US2021/036030 WO2021248086A2 (en) | 2020-06-05 | 2021-06-04 | Live attenuated respiratory syncytial virus |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112022024539A2 true BR112022024539A2 (pt) | 2022-12-27 |
Family
ID=76708442
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112022024539A BR112022024539A2 (pt) | 2020-06-05 | 2021-06-04 | Vírus sincicial respiratório vivo atenuado |
Country Status (10)
Country | Link |
---|---|
US (1) | US20230279362A1 (pt) |
EP (1) | EP4161567A2 (pt) |
JP (1) | JP2023529836A (pt) |
KR (1) | KR20230021115A (pt) |
CN (1) | CN116568323A (pt) |
AU (1) | AU2021285997A1 (pt) |
BR (1) | BR112022024539A2 (pt) |
CA (1) | CA3185143A1 (pt) |
MX (1) | MX2022015398A (pt) |
WO (1) | WO2021248086A2 (pt) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6264957B1 (en) | 1995-09-27 | 2001-07-24 | The United States Of America As Represented By The Department Of Health And Human Services | Product of infectious respiratory syncytial virus from cloned nucleotide sequences |
EP4190895A1 (en) * | 2013-02-08 | 2023-06-07 | The U.S.A. As Represented By The Secretary, Department Of Health And Human Services | Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization |
US10654898B2 (en) * | 2015-01-20 | 2020-05-19 | The United States of America, as represented by the Secretary, Department of Health and Human Serices | Recombinant human/bovine parainfluenza virus 3 (B/HPIV3) expressing a chimeric RSV/BPIV3 F protein and uses thereof |
US10655109B2 (en) * | 2015-12-11 | 2020-05-19 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Recombinant respiratory syncytial virus stains with mutations in the M2-2 ORF providing a range of attenuation phenotypes |
-
2021
- 2021-06-04 CA CA3185143A patent/CA3185143A1/en active Pending
- 2021-06-04 CN CN202180058491.3A patent/CN116568323A/zh active Pending
- 2021-06-04 WO PCT/US2021/036030 patent/WO2021248086A2/en active Application Filing
- 2021-06-04 BR BR112022024539A patent/BR112022024539A2/pt unknown
- 2021-06-04 AU AU2021285997A patent/AU2021285997A1/en active Pending
- 2021-06-04 JP JP2022574455A patent/JP2023529836A/ja active Pending
- 2021-06-04 EP EP21736442.1A patent/EP4161567A2/en active Pending
- 2021-06-04 US US18/008,393 patent/US20230279362A1/en active Pending
- 2021-06-04 MX MX2022015398A patent/MX2022015398A/es unknown
- 2021-06-04 KR KR1020237000585A patent/KR20230021115A/ko active Search and Examination
Also Published As
Publication number | Publication date |
---|---|
CN116568323A (zh) | 2023-08-08 |
JP2023529836A (ja) | 2023-07-12 |
US20230279362A1 (en) | 2023-09-07 |
AU2021285997A1 (en) | 2023-01-19 |
WO2021248086A2 (en) | 2021-12-09 |
EP4161567A2 (en) | 2023-04-12 |
WO2021248086A3 (en) | 2022-01-13 |
CA3185143A1 (en) | 2021-12-09 |
KR20230021115A (ko) | 2023-02-13 |
MX2022015398A (es) | 2023-04-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2022009429A (es) | Composiciones para la inmunizacion contra virus respiratorios. | |
CO2018005265A2 (es) | Vacunas de ácido nucleico para el virus varicela-zóster | |
CO2018005229A2 (es) | Vacuna de virus sincitial respiratorio | |
MX2022006603A (es) | Vacuna contra el virus de la influenza de amplio espectro. | |
EA201890999A1 (ru) | Вакцина против вируса простого герпеса | |
CO7160021A2 (es) | Virus del herpes aviar recombinantes multivalentes y vacunas para inmunizar especies aviares | |
CY1119284T1 (el) | ΣΩΜΑΤΙΔΙΑ ΠΑΡΟΜΟΙΑ ΜΕ ΙΟ ΓΛΥΚΟ-ΠΡΩΤΕΪΝΗΣ ΛΥΣΣΑΣ (VLPs) | |
BR112018013387A2 (pt) | vetor de vacinação recombinante, vírus mva, vacina ou composição farmacêutica e kit | |
PH12017501370A1 (en) | Bivalent swine influenza virus vaccine | |
BR112015002131A8 (pt) | Vírus vaccinia ankara modificado (mva) recombinante, composição farmacêutica e uso do referido mva recombinante | |
MX2019003682A (es) | Antigenos de consenso del virus sincitial respiratorio humano, constructos de acido nucleico y vacunas hechas de estos, y metodos para utilizarlas. | |
MX2022010588A (es) | Vacuna basada en poxvirus recombinantes contra el virus sars-cov-2. | |
IN2014MN01714A (pt) | ||
MX2018015506A (es) | Vacuna contra virus de bronquitis infecciosa. | |
EA201991041A1 (ru) | Вакцина против свиного парвовируса и вируса свиного репродуктивного и респираторного синдрома и способы ее получения | |
BR112018068342A2 (pt) | vacina de vírus zika vivo atenuado | |
MX2022010372A (es) | Vacuna contra la infeccion por el virus de la peste porcina africana. | |
CL2021003211A1 (es) | Una cepa viva modificada, del virus del síndrome respiratorio y reproductivo porcino (prrs), vacuna que lo comprende y su uso para tratar el prrs tipo ii. (divisional solicitud no. 2123-2018) | |
CO2022017989A2 (es) | Vacunas para la papilomatosis respiratoria recurrente y métodos para usar estas | |
CL2013002631A1 (es) | Virus de la necrosis pancreatica infecciosa (ipnv) avirulento porque comprende proteina vp2 madura. | |
BR112022024539A2 (pt) | Vírus sincicial respiratório vivo atenuado | |
ZA202305129B (en) | Recombinant hvt and uses thereof | |
EA202191147A1 (ru) | Вакцина виб h52 с гетерологичным шиповидным белком | |
EA202191145A1 (ru) | Вакцина виб 4/91 с гетерологичным шиповидным белком | |
BR112018011674A2 (pt) | cepas do vírus sincicial respiratório recombinante com mutações na orf de m2-2 fornecendo uma faixa de fenótipos de atenuação |